Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Manufacturing Strategies for Generics and Branded Drugs Converge
12:19 PM MDT | September 21, 2007 | Alex Scott
Generic drugs manufacturers and manufacturers of branded drugs are reassessing their manufacturing strategies in light of tightening competition in the sector, according to a recent report by Enrico T. Polastro, v.p. and senior industry specialist for Arthur D. Little Benelux (Brussels). Typically, generic drugs manufacturers outsource their bulk manufacturing, while branded drugs producers have retained much of their manufacturing in-house. The two distinct models are now converging as producers attempt to gain competitive edge through enhanced bulk ingredients...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee